Moorfields Eye Hospital NHS Foundation Trust

Running trials

• Not yet recruiting

  Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool

  NCT07704294· Source

• Not yet recruiting

  Retinal Ganglion Cell Neuroprotection Under Prostaglandin Analogues

  NCT07074782· Source

• Recruiting

  PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group

  NCT07235592· Source

• Recruiting

  A Study of 36-Week Refill Exchanges of Port Delivery System (PDS) With Ranibizumab in nAMD

  NCT06847542· Phase 3· Source

• Recruiting

  A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)

  NCT07161544· Phase 1/2· Source

• Active, not recruiting

  A Study to Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT06795048· Phase 4· Source

• Recruiting

  A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy

  NCT06541704· Phase 3· Source

• Enrolling by invitation

  Investigating Epstein-Barr Virus Associated Conjunctivitis

  NCT06689397· Source

• Active, not recruiting

  A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of Vonaprument (Formerly ANX007) in Participants With Dry Age-Related Macular Degeneration (AMD) With Geographic Atrophy (GA)

  NCT06510816· Phase 3· Source

• Active, not recruiting

  Retinal Pigment Epithelium Safety Study For Patients In B4711001

  NCT03102138· Source

• Recruiting

  Nicotinamide in Glaucoma (NAMinG): A Randomised, Placebo-controlled, Multi-centre, Phase III Trial

  NCT05405868· Phase 3· Source

• Active, not recruiting

  A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

  NCT06007690· Phase 3· Source

• Active, not recruiting

  A Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)

  NCT04657289· Phase 3· Source

• Active, not recruiting

  Restoration of Central Vision With the PRIMA System in Patients With Atrophic AMD

  NCT04676854· Source

• Active, not recruiting

  Dose-escalation Study to Evaluate the Safety and Tolerability of GS030 in Subjects With Retinitis Pigmentosa

  NCT03326336· Phase 1/2· Source

• Recruiting

  Extension Study for the Port Delivery System With Ranibizumab (Portal)

  NCT03683251· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Glaucoma3 recruiting
• Macular degeneration2 recruiting
• Multiple sclerosis1 recruiting
• Neuromyelitis optica (NMOSD)1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression

  NCT05698316· Source

• Completed

  A Study to Investigate Vamikibart (RO7200220) in Diabetic Macular Edema

  NCT05151731· Phase 2· Source

• Completed

  A Study of Implantation of Retinal Pigment Epithelium in Subjects with Acute Wet Age Related Macular Degeneration

  NCT01691261· Phase 1· Source

• Completed

  A Study to Evaluate the Long-Term Safety and Tolerability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

  NCT04777201· Phase 3· Source

• Terminated

  HORIZON: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04566445· Phase 2· Source

• Completed

  A Study to Evaluate THR-149 Treatment for Diabetic Macular Oedema

  NCT04527107· Phase 2· Source

• Terminated

  EXPLORE: A Phase II Study to Evaluate the Safety and Efficacy of Two Doses of GT005

  NCT04437368· Phase 2· Source

Trial sites

• Moorfields Eye Hospital NHS foundation Trust1 trial
• Moorfields Eye Hospital NHS Foundation Trust19 trials
• Moorfields Eye Hospital NHS Foundation Trust, 162 City Road2 trials
• Moorfields Eye Hospital NHS Foundation Trust, Moorfields Eye Hospital1 trial
• NIHR Moorfields Clinical Research Facility, Moorfields Eye Hospital, NHS Foundation Trust2 trials

Conditions

Diseases this institution publishes on or runs trials for.

• Glaucoma73 works · 3 trials
• Macular degeneration61 works · 13 trials
• Diabetic eye disease37 works · 2 trials
• Retinitis pigmentosa7 works · 2 trials